Company Ticker News February 3, 2022Biogen Inc. (BIIB) Q4 Earnings and Revenues Surpass Estimates 0 0 Share
Company Ticker News February 3, 2022Biogen's Alzheimer's Drug Clocks Q4 Sales Of Just $1M, FY22 Earnings Guidance Below Consensus 0 0 Share
Company Ticker News February 3, 2022Biogen's stock falls 3.7% on earnings miss, says it brought in $1 million in sales of Alzheimer's drug in the fourth quarter 0 0 Share
Company Ticker News February 3, 2022Biogen 2022 profit forecast misses estimates on Aduhelm woes 0 0 Share
Company Ticker News February 1, 2022Biogen Exercises Option To Participate Developing Genentech's Bispecific Antibody, Mosunetuzumab 0 0 Share
Press Release February 1, 2022Biogen Exercises Option to Participate in the Development and Commercialization of a Late-Stage Bispecific Antibody 0 0 Share
Company Ticker News January 31, 2022Is a Beat Likely for Biogen (BIIB) This Earnings Season? 0 0 Share
Press Release January 31, 2022Biogen Announces Nancy Leaming and Brian Posner to Retire from Board of Directors 0 0 Share
